Molina Healthcare, Inc $MOH Stake Reduced by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. reduced its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 97.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 656 shares of the company’s stock after selling 22,983 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Molina Healthcare were worth $109,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in MOH. Torren Management LLC bought a new position in Molina Healthcare during the 4th quarter worth $26,000. Miller Global Investments LLC bought a new position in Molina Healthcare during the 4th quarter worth $27,000. Cromwell Holdings LLC grew its stake in Molina Healthcare by 211.9% during the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after buying an additional 125 shares during the last quarter. Rakuten Securities Inc. grew its stake in Molina Healthcare by 5,020.0% during the 4th quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock worth $44,000 after buying an additional 251 shares during the last quarter. Finally, MUFG Securities EMEA plc bought a new position in Molina Healthcare during the 2nd quarter worth $48,000. 98.50% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares in the company, valued at $12,502,611. This represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 1.44% of the company’s stock.

Molina Healthcare Trading Down 0.0%

Shares of MOH stock opened at $184.08 on Monday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $312.85. The stock has a fifty day moving average of $160.73 and a two-hundred day moving average of $159.88. The firm has a market capitalization of $9.59 billion, a PE ratio of 54.46 and a beta of 0.85.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same quarter in the previous year, the firm posted $6.08 EPS. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, research analysts expect that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages recently commented on MOH. The Goldman Sachs Group lowered their price objective on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research note on Wednesday, February 11th. Cantor Fitzgerald upped their price objective on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $129.00 price objective on shares of Molina Healthcare in a research note on Friday, April 24th. Zacks Research upgraded Molina Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Finally, Wells Fargo & Company boosted their price target on Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a research report on Monday, April 27th. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $176.00.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.